Nature’s brain protectors

A large study by the Mayo Clinic found that in the last three decades [Click here](1770d7/ct0_0/1/ms?sid=TV2%3AH1NL3qMis) to view this message in your browser | [Click here](1770d7/l-002e/zout?sid=TV2%3AH1NL3qMis) to stop receiving our messages [] [] Al Sears, MD 11905 Southern Blvd. Royal Palm Beach, FL 33411 [] October 3, 2023 [] Reader, A large study by the Mayo Clinic found that in the last three decades, your risk of developing Parkinson’s jumped almost 20%. [copper skin] For those over age 70, the risk increases by 35% every 10 years. Traditional doctors believe the only way to treat Parkinson’s disease is with a Big Pharma drug. But now they’re convinced that putting one alien, lab-created chemical into the body isn’t enough... And they want patients to double up.1 Researchers call this latest dual drug combo a “new option for initiating treatment.” And, of course, when you double the number of drugs you take, it means you are potentially doubling the devastating side effects. Some of the more troubling consequences associated with Parkinson’s drugs include: - Dyskinesias: Uncontrolled, involuntary movements, including uncontrollable jerking and sustained muscle contractions. - Hypotension. A significant drop in blood pressure leads to dizziness and an increased risk of falling. - Hallucinations: Seeing or hearing things that are not there. - Sleep disturbances: Including insomnia and excessive daytime sleepiness. - Loss of cognitive function: Impaired memory, attention, and executive functions, as well as mood swings, depression, and anxiety. - Impulse control disorders. This can lead to gambling, hypersexuality, extreme spending, or binge eating. Parkinson’s disease is a progressive neurodegenerative brain condition that destroys cells in the area of your brain that controls movement. Sufferers have a diminished supply of dopamine because the nerve cells that produce it have died. The less dopamine you make, the less control you have over your movements. Try Nature’s Proven Brain Protectors For three decades, I’ve helped my patients prevent Parkinson’s and protect their brains using natural, dopamine-enhancing supplements. Here are three you can try at home. - L-carnitine. L-carnitine is an amino acid that enhances memory and improves muscle control. Your body converts L-carnitine into acetyl-L-carnitine (ALC). Studies show ALC prevents brain aging and slows the progress of brain diseases.2 It also improves cell receptors so neurons can take up more dopamine, the neurotransmitter critical for motor skills and mental focus. And it helps prevent the death of cells that produce dopamine. 3 I suggest supplementing with at least 500 mg of ALC every day on an empty stomach. Look for a formula with only L-carnitine and not D, L-carnitine. The D form is synthetic. - Vitamin B12. According to research conducted at the Icahn School of Medicine at Mount Sinai and published in the journal Cell Research, vitamin B12 can inhibit the activity of a protein implicated in certain cases of Parkinson's disease. 4 B12 is also a key nutrient for nervous system health. It is important for producing dopamine, and recent studies show that a B12 deficiency is common in Parkinson’s patients.5 - Green tea. An excellent way to protect the dopamine-producing regions of your brain is by drinking plenty of green tea each day. One meta-study suggested the risk of Parkinson’s drops by 26% for every two cups of tea consumed daily. 6 You see, green tea is loaded with a unique kind of flavonoid called catechins. There’s also strong evidence that high levels of EGCG in green tea also protect against Parkinson’s. 7 But buyer beware: When it comes to catechin content, it’s hard to know what you’re getting in commercial teas. I’ve only found one brand that delivered anywhere close to my recommended 50 mg dose. Called Teavana Green Tea Gyokuro, it provides 86 mg per serving. To maximize antioxidant content, pour boiling – not just hot – water over your tea leaves and let steep for 10 minutes before drinking. To Your Good Health, Al Sears, MD, CNS --------------------------------------------------------------- References: - Parkinson’s News Today. “A phase 3 study with P2B001 in subjects with early Parkinson’s.” clinicaltrials.gov/ct2/show/NCT03329508. Accessed on September 28, 2023. - Arrigo A, et al. “Effects of acetyl-L-carnitine on reaction times in patients with cerebrovascular insufficiency.” Int J Clin Pharmacol Res. 1990;10(1-2):133-7. - Bodis-Wollner E, et al. “Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates.” J Neural Transm Park Dis Diment Sci. 1991;3(1):63-72. - Schaffner A, et al. “Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection.” Cell Research. 2019; 29:313–329. - Dietiker C, et al. “Characterization of vitamin B12 supplementation and correlation with clinical outcomes in a large longitudinal study of early Parkinson’s Disease.” J Mov Disord. 2019 May; 12(2): 91–96. - GuoZ, et al. “ Association of lung cancer and tea-drinking habits of different subgroup populations: meta-analysis of case-control studies and cohort studies.” Iran J Public Health. 2019 Sep; 48(9): 1566–1576. - Malar D, et al. “Neuroprotective properties of green tea (Camellia Sinensis) in Parkinson’s disease: A review.” Molecules. 2020;25(17):3926. --------------------------------------------------------------- alsearsmd@send.alsearsmd.com [Preferences | Unsubscribe](1770d7/l-002e/zout?sid=TV2%3AH1NL3qMis) 11905 Southern Blvd., Royal Palm Beach, Florida 33411, United States